biosimilar pharmaceuticals

Preferred Label : biosimilar pharmaceuticals;

Obsolete resource : false;

MeSH definition : BIOLOGIC PRODUCTS that are imitations but not exact replicas of innovator products.; Biological products that are imitations but not exact replicas of innovator biological products.;

MeSH synonym : pharmaceuticals, biosimilar; Follow-on Biologics; Biologics, Follow-on; Follow on Biologics; Subsequent Entry Biologics; Biologics, Subsequent Entry;

MeSH Hyperonym : Biosimilars; Biosimilar;

Wikipedia link : https://en.wikipedia.org/wiki/Biosimilar;

Is substance : O;

Details

Origin ID

D059451;

UMLS CUI

C3178809;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Biosimilarity Study [NCIt concept]
Record concept(s)
- Biosimilars [MeSH concept]
- biosimilar pharmaceuticals [MeSH concept]
Related MeSH Supplementary Concept(s)
- ABP 501 [MeSH Supplementary Concept]
- ABP-980 [MeSH Supplementary Concept]
- BCD-055 [MeSH Supplementary Concept]
- BEVZ92 [MeSH Supplementary Concept]
- BI 695501 [MeSH Supplementary Concept]
- CT-P17 [MeSH Supplementary Concept]
- CT-P6 [MeSH Supplementary Concept]
- FKB327 [MeSH Supplementary Concept]
- GP1111 [MeSH Supplementary Concept]
- GP2015 [MeSH Supplementary Concept]
- GP2017 [MeSH Supplementary Concept]
- MK-1293 [MeSH Supplementary Concept]
- MYL-1401H [MeSH Supplementary Concept]
- MYL-1501D [MeSH Supplementary Concept]
- Ogivri [MeSH Supplementary Concept]
- Ontruzant [MeSH Supplementary Concept]
- PF-06410293 [MeSH Supplementary Concept]
- QL1206 [MeSH Supplementary Concept]
- RGB-10 [MeSH Supplementary Concept]
- SB2 infliximab [MeSH Supplementary Concept]
- TKN732 [MeSH Supplementary Concept]
- adalimumab biosimilar HS016 [MeSH Supplementary Concept]
- etanercept biosimilar SB4 [MeSH Supplementary Concept]
- trastuzumab biosimilar HD201 [MeSH Supplementary Concept]
- trastuzumab biosimilar HLX02 [MeSH Supplementary Concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- Biosimilar [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients